Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.
Samarakoon U, Wolfson AR, Zhou L, Bassir F, Phillips E, Kroshinsky D, Cucka B, Biglione B, Phadke NA, Jaggers J, Byrne EC, Judd AD, Blumenthal KG. Samarakoon U, et al. Among authors: phillips e. J Am Acad Dermatol. 2024 Aug;91(2):370-373. doi: 10.1016/j.jaad.2024.04.036. Epub 2024 Apr 26. J Am Acad Dermatol. 2024. PMID: 38677336 No abstract available.
Drug allergy: A 2022 practice parameter update.
Khan DA, Banerji A, Blumenthal KG, Phillips EJ, Solensky R, White AA, Bernstein JA, Chu DK, Ellis AK, Golden DBK, Greenhawt MJ, Horner CC, Ledford D, Lieberman JA, Oppenheimer J, Rank MA, Shaker MS, Stukus DR, Wallace D, Wang J; Chief Editor(s):; Khan DA, Golden DBK, Shaker M, Stukus DR; Workgroup Contributors:; Khan DA, Banerji A, Blumenthal KG, Phillips EJ, Solensky R, White AA; Joint Task Force on Practice Parameters Reviewers:; Bernstein JA, Chu DK, Ellis AK, Golden DBK, Greenhawt MJ, Horner CC, Ledford D, Lieberman JA, Oppenheimer J, Rank MA, Shaker MS, Stukus DR, Wallace D, Wang J. Khan DA, et al. J Allergy Clin Immunol. 2022 Dec;150(6):1333-1393. doi: 10.1016/j.jaci.2022.08.028. Epub 2022 Sep 17. J Allergy Clin Immunol. 2022. PMID: 36122788 No abstract available.
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA. Wei BM, et al. J Am Acad Dermatol. 2024 May;90(5):885-908. doi: 10.1016/j.jaad.2023.02.072. Epub 2023 Jul 27. J Am Acad Dermatol. 2024. PMID: 37516359 Review.
Drug allergy in older adults: A study from the United States Drug Allergy Registry.
Accarino JJO, Ramsey A, Samarakoon U, Phillips E, Gonzalez-Estrada A, Otani IM, Fu X, Banerji A, Stone CA Jr, Khan DA, Blumenthal KG; United States Drug Allergy Registry Study Team. Accarino JJO, et al. Among authors: phillips e. Ann Allergy Asthma Immunol. 2023 Nov;131(5):628-636.e2. doi: 10.1016/j.anai.2023.07.024. Epub 2023 Aug 7. Ann Allergy Asthma Immunol. 2023. PMID: 37557950
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color.
Bassir F, Alvarez-Arango S, Kroshinsky D, Phillips E, Ezeofor AJ, Samarakoon U, Blackley SV, Wang L, Zhou L, Blumenthal KG. Bassir F, et al. Among authors: phillips e. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3537-3540. doi: 10.1016/j.jaip.2023.08.009. Epub 2023 Aug 10. J Allergy Clin Immunol Pract. 2023. PMID: 37572756 Free PMC article. No abstract available.
1,759 results